Type 1 diabetes

With Grandma as Inspiration: Refusing to Let the Diagnosis Limit Her
Silje Elfrida (36) lives in Tjodalyng, near Larvik, works in the healthcare sector, and leads a busy life with two very active sons aged seven and five. At the same time, she is navigating an uncertain romantic situation. Diagnosed with type 1 diabetes at the age of 19 in 2007, Silje Elfrida took on the challenge immediately, determined not to let the condition limit her life.

Ingunn’s Son Was Diagnosed with Type 1 Diabetes: "I Wish I Had Known More in Advance"
Unpredictable blood glucose readings, extreme fatigue, and an overwhelming fear of low blood glucose—this is how Ingunn describes the early days after her son, Olav, was diagnosed with type 1 diabetes. It has been a time of sleepless nights and many worries. But it has also been a time of learning, adaptation, and strengthened family bonds.

Need to identify risk of developing autoimmune type 1 diabetes? Test for autoantibodies!
Anti-islet autoantibodies that target proteins associated with beta-cells serve as biomarkers of autoimmune type 1 diabetes (T1D) development.1 The number of detectable autoantibodies through screening correlates with risk of developing autoimmune T1D.2 Assays for detecting autoimmune T1D have shown high sensitivity and specificity.3,4

Autoimmune Type 1 Diabetes
The Type 1 Diabetes (T1D) field is evolving.
Recognition of the presymptomatic stages in T1D is growing.1-4
The clinical benefits of early detection of T1D are being highlighted.3-4 Programmes focusing on early detection through testing and screening for presymptomatic autoimmune T1D are increasingly offered to risk populations and the general population.1,2

Global Developments in Early Detection of Autoimmune Type 1 Diabetes
Curious about the characteristics of pre-symptomatic- and stage 3 Type 1 Diabetes? Interested in learning about the potential benefits of screening for autoimmune Type 1 Diabetes?
This short film gives you an overview of recent developments in diagnosis of Type 1 Diabetes, showcasing how early detection efforts can benefit those who need it the most.

Detectability of Autoimmune Type 1 Diabetes
Systematic early detection of autoimmune Type 1 Diabetes might be a new way to avoid acute and chronic complications of the condition.1-5 This new approach may play a role as a revolutionary shift, helping to shape the future of Type 1 Diabetes management.2

Infographic: Impact of Type 1 Diabetes Diagnosis
This infographic summarizes survey data* about the impact that families across the Nordic countries have felt when being diagnosed with autoimmune Type 1 Diabetes (T1D).
Leave site modal
Du er i ferd med å forlate campus.sanofi/no. Sanofi er ikke ansvarlig for innholdet på dette eksterne Nettstedet.
Jobber du innen helsevesenet?
Denne nettsiden inneholder informasjon som er kun for helsepersonell som lege, tannlege, offentlig godkjent sykepleier, farmasøyt, optiker, tannpleier, samt studenter i disse fag.